Organization

Unity Health Toronto

23 clinical trials

1 abstract

Clinical trial
Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
Status: Active (not recruiting), Estimated PCD: 2024-01-15
Clinical trial
Role of Active Deresuscitation After Resuscitation: The RADAR-Canada Pilot Clinical Trial
Status: Not yet recruiting, Estimated PCD: 2025-03-31
Clinical trial
Doxycycline Crossover Trial for Hereditary Hemorrhagic Telangiectasia
Status: Active (not recruiting), Estimated PCD: 2022-12-15
Clinical trial
Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Status: Completed, Estimated PCD: 2019-08-30
Clinical trial
Low-dose Sirolimus for Nosebleeds in HHT: A Phase II Pilot Study
Status: Recruiting, Estimated PCD: 2024-11-27
Clinical trial
CanROC Epinephrine Dose: Optimal Versus Standard Evaluation Trial (CanROC EpiDOSE Trial)
Status: Recruiting, Estimated PCD: 2027-12-01
Clinical trial
Empagliflozin and Cardiac Remodelling in People Without Diabetes
Status: Completed, Estimated PCD: 2022-07-31
Clinical trial
Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings
Status: Recruiting, Estimated PCD: 2024-01-01
Clinical trial
Phage Therapy for the Treatment of Urinary Tract Infection
Status: Active (not recruiting), Estimated PCD: 2023-07-28
Clinical trial
Cryoneurolysis for Pain Management After Total Knee Arthroplasty - a Pilot Study
Status: Recruiting, Estimated PCD: 2023-10-01
Abstract
Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR+ breast cancer in the TEAM trial.
Org: Cancer Research UK Scotland Centre, University of Edinburgh Cancer Research UK Centre, Unity Health Toronto, Biotheranostics, A Hologic Company, A Hologic Company,